1. Home
  2. KALV vs NPK Comparison

KALV vs NPK Comparison

Compare KALV & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo National Presto Industries Inc.

NPK

National Presto Industries Inc.

HOLD

Current Price

$141.94

Market Cap

941.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
NPK
Founded
N/A
1905
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
941.1M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
KALV
NPK
Price
$26.72
$141.94
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.60
N/A
AVG Volume (30 Days)
4.1M
59.7K
Earning Date
07-09-2026
05-07-2026
Dividend Yield
N/A
0.71%
EPS Growth
N/A
N/A
EPS
N/A
0.99
Revenue
$50,000,000.00
$503,524,000.00
Revenue This Year
$185.42
N/A
Revenue Next Year
$59.23
N/A
P/E Ratio
N/A
$137.87
Revenue Growth
495.66
29.70
52 Week Low
$9.83
$82.67
52 Week High
$26.85
$149.86

Technical Indicators

Market Signals
Indicator
KALV
NPK
Relative Strength Index (RSI) 75.25 52.87
Support Level $14.66 $129.58
Resistance Level N/A $148.70
Average True Range (ATR) 0.57 6.22
MACD 0.45 -0.44
Stochastic Oscillator 98.41 70.91

Price Performance

Historical Comparison
KALV
NPK

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

Share on Social Networks: